View in EDS HTML Full Text PDF Full Text

Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis.

Saved in:
Bibliographic Details
Title: Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis.
Authors: Reinisch, Walter1 (AUTHOR), Loftus, Edward V2 (AUTHOR), Schreiber, Stefan3 (AUTHOR), Rubin, David T4 (AUTHOR), Louis, Edouard5 (AUTHOR), Hecht, Patrick M6 (AUTHOR), Barrachina, Elena Marced6 (AUTHOR), Kalabic, Jasmina7 (AUTHOR), Vladea, Ramona6 (AUTHOR), Sharma, Dolly6 (AUTHOR), Duan, Weijiang Rachel6 (AUTHOR), Zhang, Yafei6 (AUTHOR), Panaccione, Remo8 (AUTHOR)
Source: Journal of Crohn's & Colitis. Apr2025, Vol. 19 Issue 4, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18739946
DOI:10.1093/ecco-jcc/jjaf025